Contact Us
Biotech Collaborations Global Market Report 2025
Global Biotech Collaborations Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Biotech Collaborations Global Market Report 2025

By Collaboration Type (Research And Development Collaborations, Licensing Agreements, Joint Ventures, Mergers Or Acquisitions, Other Collaborations); By Application (Drug Discovery, Clinical Research, Diagnostics, Therapeutics, Other Applications); By End User (Pharmaceutical Companies, Biotechnology Firms, Other End-Users); Subsegments:; By Research And Development Collaborations (Preclinical Research); By Licensing Agreements (Exclusive Licensing, Non Exclusive Licensing, In Licensing, Out Licensing); By Joint Ventures (Strategic Alliance, Co Development, Co Marketing, Technology Sharing); By Mergers Or Acquisitions (Horizontal Merger, Acquisition Of Assets); By Other Collaborations (Research Consortium, Contract Research) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biotech Collaborations Market Overview

• Biotech Collaborations market size has reached to $84.59 billion in 2024

• Expected to grow to $144.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%

• Growth Driver: Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Targeted Therapies

• Market Trend: Innovative Partnerships Aim To Deliver More Effective And Cost-Efficient Therapies

North America was the largest region in 2024.

What Is Covered Under Biotech Collaborations Market?

Biotech collaborations refer to strategic partnerships between biotechnology companies, research institutions, or other organizations aimed at jointly developing, researching, or commercializing biotechnological products and innovations. These collaborations enable the sharing of expertise, resources, and technologies to accelerate innovation, reduce risks, and bring advanced biotech solutions to market more efficiently.

The main collaboration types of biotech collaborations are research and development collaborations, licensing agreements, joint ventures, mergers or acquisitions, and other collaborations. Research and development (R&D) collaborations refer to strategic partnerships between two or more organizations to jointly conduct scientific research and develop new products, technologies, or processes. These collaborations support various applications, including drug discovery, clinical research, diagnostics, therapeutics, and others, and cater to diverse end users such as pharmaceutical companies, biotechnology firms, academic and research institutes, and others.

Biotech Collaborations Market Size and growth rate 2025 to 2029: Graph

What Is The Biotech Collaborations Market Size 2025 And Growth Rate?

The biotech collaborations market size has grown rapidly in recent years. It will grow from $84.59 billion in 2024 to $94.35 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increasing demand for novel therapeutics, growing research and development expenditure, rising prevalence of chronic diseases, increasing regulatory complexities, and growing adoption of advanced biotechnologies.

What Is The Biotech Collaborations Market Growth Forecast?

The biotech collaborations market size is expected to see rapid growth in the next few years. It will grow to $144.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growing investments in biotech startups, increasing demand for sustainable and green bioprocesses, growing focus on personalized medicine, rising adoption of gene and cell therapies, and growing need for cost optimization. Major trends in the forecast period include developing next-generation biologics, integration of omics data, integration of digital health technologies, innovation in drug delivery systems, and developing sustainable bioprocesses.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Biotech Collaborations Market Segmented?

1) By Collaboration Type: Research And Development Collaborations, Licensing Agreements, Joint Ventures, Mergers Or Acquisitions, Other Collaborations

2) By Application: Drug Discovery, Clinical Research, Diagnostics, Therapeutics, Other Applications

3) By End User: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Research And Development Collaborations: Preclinical Research, Clinical Trials, Translational Research, Drug Discovery

2) By Licensing Agreements: Exclusive Licensing, Non Exclusive Licensing, In Licensing, Out Licensing

3) By Joint Ventures: Strategic Alliance, Co Development, Co Marketing, Technology Sharing

4) By Mergers Or Acquisitions: Horizontal Merger, Vertical Merger, Conglomerate Merger, Acquisition Of Assets

5) By Other Collaborations: Research Consortium, Public Private Partnership, Academic Collaboration, Contract Research

What Is Driving The Biotech Collaborations Market? Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Targeted Therapies

The increasing demand for personalized medicine is expected to propel the growth of the biotech collaborations market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Biotech collaborations accelerate the advancement of personalized medicine by combining expertise and innovative technologies, enabling the development of targeted therapies for individual patients. They reduce research timelines and improve success rates, enhancing treatment efficacy and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the biotech collaborations industry.

Who Are The Major Players In The Global Biotech Collaborations Market?

Major companies operating in the biotech collaborations market are Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly And Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., C.H. Boehringer Sohn AG & Co. KG, CSL Limited., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, and Biogen Inc.

What Are The Key Trends Of The Global Biotech Collaborations Market? Innovative Partnerships Aim To Deliver More Effective And Cost-Efficient Therapies

Major companies operating in the biotech collaborations market are focusing on developing innovative solutions, such as artificial intelligence-driven drug discovery platforms, to accelerate the identification of novel therapeutics and improve research and development efficiency. Artificial intelligence-driven drug discovery platforms use advanced algorithms and machine learning to analyze biological data, predict drug-target interactions, and streamline the development of new therapeutics. For instance, in January 2025, Iktos S.A.S., a France-based biotechnology company, collaborated with Cube Biotech GmbH, a Germany-based biotechnology company, to develop novel small molecule agonists targeting the amylin receptor, a promising therapeutic target for cardiometabolic disorders, including obesity, diabetes, and metabolic dysfunction-associated steatotic hepatitis (MASH). This partnership leverages Iktos’ generative AI-driven drug discovery and robotic synthesis platform alongside Cube Biotech’s advanced NativeMP membrane protein technology, protein stabilization methods, and biophysical assay expertise. The collaboration seeks to accelerate drug discovery timelines, enhance success rates, and address challenging membrane protein targets more effectively, offering potential therapies that could be more efficient and cost-effective than existing treatments such as GLP-1 receptor agonists.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Biotech Collaborations Market? Stryker Acquires Inari Medical To Expand Peripheral Vascular And VTE Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical industry company, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to strengthen its oncology portfolio, expand its pipeline of targeted cancer therapies, and drive long-term revenue growth. Seagen Inc. is a US-based biopharmaceutical company that has forged strategic collaborations to advance its oncology pipeline.

What Is The Regional Outlook For The Global Biotech Collaborations Market?

North America was the largest region in the biotech collaborations market in 2024. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biotech Collaborations Market?

The biotech collaborations market includes revenues earned by entities through clinical trial services, licensing and technology transfer, manufacturing and contract development, regulatory and consulting services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biotech Collaborations Industry?

The biotech collaborations market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biotech collaborations industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Table Of Contents

1. Executive Summary

2. Biotech Collaborations Market Characteristics

3. Biotech Collaborations Market Trends And Strategies

4. Biotech Collaborations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biotech Collaborations Growth Analysis And Strategic Analysis Framework

5.1. Global Biotech Collaborations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biotech Collaborations Market Growth Rate Analysis

5.4. Global Biotech Collaborations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biotech Collaborations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biotech Collaborations Total Addressable Market (TAM)

6. Biotech Collaborations Market Segmentation

6.1. Global Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research And Development Collaborations

Licensing Agreements

Joint Ventures

Mergers Or Acquisitions

Other Collaborations

6.2. Global Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Discovery

Clinical Research

Diagnostics

Therapeutics

Other Applications

6.3. Global Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Firms

Academic And Research Institutes

Other End-Users

6.4. Global Biotech Collaborations Market, Sub-Segmentation Of Research And Development Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical Research

Clinical Trials

Translational Research

Drug Discovery

6.5. Global Biotech Collaborations Market, Sub-Segmentation Of Licensing Agreements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Exclusive Licensing

Non Exclusive Licensing

In Licensing

Out Licensing

6.6. Global Biotech Collaborations Market, Sub-Segmentation Of Joint Ventures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Strategic Alliance

Co Development

Co Marketing

Technology Sharing

6.7. Global Biotech Collaborations Market, Sub-Segmentation Of Mergers Or Acquisitions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Horizontal Merger

Vertical Merger

Conglomerate Merger

Acquisition Of Assets

6.8. Global Biotech Collaborations Market, Sub-Segmentation Of Other Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Consortium

Public Private Partnership

Academic Collaboration

Contract Research

7. Biotech Collaborations Market Regional And Country Analysis

7.1. Global Biotech Collaborations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biotech Collaborations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotech Collaborations Market

8.1. Asia-Pacific Biotech Collaborations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotech Collaborations Market

9.1. China Biotech Collaborations Market Overview

9.2. China Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotech Collaborations Market

10.1. India Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotech Collaborations Market

11.1. Japan Biotech Collaborations Market Overview

11.2. Japan Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotech Collaborations Market

12.1. Australia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotech Collaborations Market

13.1. Indonesia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotech Collaborations Market

14.1. South Korea Biotech Collaborations Market Overview

14.2. South Korea Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotech Collaborations Market

15.1. Western Europe Biotech Collaborations Market Overview

15.2. Western Europe Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotech Collaborations Market

16.1. UK Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotech Collaborations Market

17.1. Germany Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotech Collaborations Market

18.1. France Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotech Collaborations Market

19.1. Italy Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotech Collaborations Market

20.1. Spain Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotech Collaborations Market

21.1. Eastern Europe Biotech Collaborations Market Overview

21.2. Eastern Europe Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotech Collaborations Market

22.1. Russia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotech Collaborations Market

23.1. North America Biotech Collaborations Market Overview

23.2. North America Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotech Collaborations Market

24.1. USA Biotech Collaborations Market Overview

24.2. USA Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotech Collaborations Market

25.1. Canada Biotech Collaborations Market Overview

25.2. Canada Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotech Collaborations Market

26.1. South America Biotech Collaborations Market Overview

26.2. South America Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotech Collaborations Market

27.1. Brazil Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotech Collaborations Market

28.1. Middle East Biotech Collaborations Market Overview

28.2. Middle East Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotech Collaborations Market

29.1. Africa Biotech Collaborations Market Overview

29.2. Africa Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotech Collaborations Market Competitive Landscape And Company Profiles

30.1. Biotech Collaborations Market Competitive Landscape

30.2. Biotech Collaborations Market Company Profiles

30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biotech Collaborations Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Sanofi S.A.

31.3. Novartis AG

31.4. AstraZeneca plc

31.5. Bristol-Myers Squibb Company

31.6. GlaxoSmithKline plc

31.7. Eli Lilly And Company

31.8. Novo Nordisk A/S

31.9. Takeda Pharmaceutical Company Limited

31.10. Amgen Inc.

31.11. Gilead Sciences Inc.

31.12. C.H. Boehringer Sohn AG & Co. KG

31.13. CSL Limited.

31.14. Regeneron Pharmaceuticals Inc.

31.15. Vertex Pharmaceuticals Incorporated

32. Global Biotech Collaborations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotech Collaborations Market

34. Recent Developments In The Biotech Collaborations Market

35. Biotech Collaborations Market High Potential Countries, Segments and Strategies

35.1 Biotech Collaborations Market In 2029 - Countries Offering Most New Opportunities

35.2 Biotech Collaborations Market In 2029 - Segments Offering Most New Opportunities

35.3 Biotech Collaborations Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biotech Collaborations Market, Sub-Segmentation Of Research And Development Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biotech Collaborations Market, Sub-Segmentation Of Licensing Agreements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biotech Collaborations Market, Sub-Segmentation Of Joint Ventures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biotech Collaborations Market, Sub-Segmentation Of Mergers Or Acquisitions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Biotech Collaborations Market, Sub-Segmentation Of Other Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Biotech Collaborations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Biotech Collaborations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Johnson And Johnson Financial Performance
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: Merck And Co. Inc. Financial Performance
  • Table 82: Pfizer Inc. Financial Performance
  • Table 83: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biotech Collaborations Market, Sub-Segmentation Of Research And Development Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biotech Collaborations Market, Sub-Segmentation Of Licensing Agreements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biotech Collaborations Market, Sub-Segmentation Of Joint Ventures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biotech Collaborations Market, Sub-Segmentation Of Mergers Or Acquisitions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Biotech Collaborations Market, Sub-Segmentation Of Other Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Biotech Collaborations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Biotech Collaborations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Johnson And Johnson Financial Performance
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: Merck And Co. Inc. Financial Performance
  • Figure 82: Pfizer Inc. Financial Performance
  • Figure 83: AbbVie Inc. Financial Performance

Frequently Asked Questions

Biotech collaborations refer to strategic partnerships between biotechnology companies, research institutions, or other organizations aimed at jointly developing, researching, or commercializing biotechnological products and innovations. These collaborations enable the sharing of expertise, resources, and technologies to accelerate innovation, reduce risks, and bring advanced biotech solutions to market more efficiently. For further insights on this market, request a sample here

The market major growth driver - Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Targeted Therapies. For further insights on this market, request a sample here

The biotech collaborations market size has grown rapidly in recent years. It will grow from $84.59 billion in 2024 to $94.35 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increasing demand for novel therapeutics, growing research and development expenditure, rising prevalence of chronic diseases, increasing regulatory complexities, and growing adoption of advanced biotechnologies. The biotech collaborations market size is expected to see rapid growth in the next few years. It will grow to $144.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growing investments in biotech startups, increasing demand for sustainable and green bioprocesses, growing focus on personalized medicine, rising adoption of gene and cell therapies, and growing need for cost optimization. Major trends in the forecast period include developing next-generation biologics, integration of omics data, integration of digital health technologies, innovation in drug delivery systems, and developing sustainable bioprocesses. For further insights on this market, request a sample here

The biotech collaborations market covered in this report is segmented as
1) By Collaboration Type: Research And Development Collaborations, Licensing Agreements, Joint Ventures, Mergers Or Acquisitions, Other Collaborations
2) By Application: Drug Discovery, Clinical Research, Diagnostics, Therapeutics, Other Applications
3) By End User: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutes, Other End-Users Subsegments:
1) By Research And Development Collaborations: Preclinical Research, Clinical Trials, Translational Research, Drug Discovery
2) By Licensing Agreements: Exclusive Licensing, Non Exclusive Licensing, In Licensing, Out Licensing
3) By Joint Ventures: Strategic Alliance, Co Development, Co Marketing, Technology Sharing
4) By Mergers Or Acquisitions: Horizontal Merger, Vertical Merger, Conglomerate Merger, Acquisition Of Assets
5) By Other Collaborations: Research Consortium, Public Private Partnership, Academic Collaboration, Contract Research For further insights on this market,
request a sample here

North America was the largest region in the biotech collaborations market in 2024. The regions covered in biotech collaborations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the biotech collaborations market are Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly And Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., C.H. Boehringer Sohn AG & Co. KG, CSL Limited., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, and Biogen Inc. For further insights on this market, request a sample here.

Major trends in this market include Innovative Partnerships Aim To Deliver More Effective And Cost-Efficient Therapies For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon